Bristol-Myers Squibb Company
BMY · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $48.2B | $48.3B | −0.2% |
| Operating income | $10.0B | −$7.49B | |
| Net income | $7.05B | −$8.95B |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 29, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $13.1B | $12.2B | +6.9% |
| Operating income | $2.54B | $3.11B | −18.6% |
| Net income | $2.16B | $2.20B | −1.8% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Bristol Myers Squibb's revenue in FY2025?
- $48.2B in FY2025 (Fiscal year ended Dec 31, 2025), −0.2% vs $48.3B a year earlier, per its 10-K filed Feb 2026.
- Was Bristol Myers Squibb profitable in FY2025?
- Yes: net income was $7.05B and operating income $10.0B in FY2025.
- What was Bristol Myers Squibb's revenue in Q3 2026?
- $13.1B (+6.9% vs a year earlier), per its Form 10-Q filed Oct 29, 2026.